Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.8 USD | +0.87% | +8.75% | -19.40% |
May. 15 | Earnings Flash (CDTX) CIDARA THERAPEUTICS Posts Q1 Revenue $8.5M | MT |
May. 15 | Cidara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 69
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Antifungal and Antiviral Drugs
100.0
%
| 64 | 100.0 % | 64 | 100.0 % | -0.60% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 64 | 100.0 % | 64 | 100.0 % | -0.60% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 13-12-31 |
Preetam Shah
DFI | Director of Finance/CFO | 51 | 21-08-31 |
Les Tari
CTO | Chief Tech/Sci/R&D Officer | 57 | 12-12-31 |
Taylor Sandison
CTO | Chief Tech/Sci/R&D Officer | 52 | 15-09-30 |
Shane Ward
COO | Chief Operating Officer | 49 | 21-08-31 |
Corporate Officer/Principal | - | 23-08-15 | |
Allison Lewis
HRO | Human Resources Officer | - | 15-01-31 |
General Counsel | - | 13-12-31 | |
Laura A. Navalta
PRN | Corporate Officer/Principal | - | 17-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Burgess
CHM | Chairman | 62 | 14-03-31 |
Director/Board Member | 69 | 14-03-31 | |
Jeffrey Stein
CEO | Chief Executive Officer | 69 | 13-12-31 |
Chrysa Mineo
BRD | Director/Board Member | 59 | 18-02-28 |
Bonnie Bassler
BRD | Director/Board Member | 61 | 21-01-21 |
Director/Board Member | 50 | 21-01-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,561,708 | 4,227,063 ( 92.66 %) | 0 | 92.66 % |
Company contact information
Cidara Therapeutics, Inc.
6310 Nancy Ridge Drive Suite 101
92121, San Diego
+858 752 6170
http://www.cidara.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.09% | 57.89M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.03% | 21.96B | |
-8.05% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- CDTX Stock
- Company Cidara Therapeutics, Inc.